MedPath

Effect of Leech therapy in Diabetic Peripheral Neuropathy

Phase 3
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Registration Number
CTRI/2023/07/055358
Lead Sponsor
Institute of Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of both the genders having the age between 30 to 75 years.

Presence of any classical symptoms i.e., pain, burning sensation, numbness, tingling sensation, insensitivity to Vibration and hot or cold in feet.

Patients with clinical positive history of diabetes mellitus having the symptoms of diabetic peripheral neuropathy will be selected for the present study.

Patients having BSL (FBS <200 mg/dl & PPBS <400 mg/dl).

Exclusion Criteria

Patients having any other associated clinical conditions influencing peripheral nerve function. (like Chronic Kidney Disease)

Age below 30 years and above 75 years.

Patients having BSL (FBS >200 mg/dl & PPBS >400 mg/dl).

Pregnancy and Lactating women.

Severe Anaemia (Hb <6 g/dl).

Haemolytic disorders â?? ITP (Immune thrombocytopenia), Haemophillia, and Thalassemia contraindicated / unfit for Jalaukavacharana (Leech Therapy).

Blood borne infections.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensations by Neuropathy Analyzer Vibrotherm Diagnostic testTimepoint: Baseline, Third week and Six Week
Secondary Outcome Measures
NameTimeMethod
Ankle reflexes by MNSITimepoint: Baseline, Third week & Six Week;Appearance of feet by MNSITimepoint: Baseline, Third week & Six Week;Foot Ulceration by MNSITimepoint: Baseline, Third week & Six Week;Monofilament test by MNSITimepoint: Baseline, Third week & Six Week;Vibration perception by MNSITimepoint: Baseline, Third week & Six Week
© Copyright 2025. All Rights Reserved by MedPath